Abstract
Among the central goals of stress neurobiology research is to understand the mechanisms by which stressors change neural circuit function to precipitate or exacerbate psychiatric symptoms. Yet despite decades of effort, psychiatric medications that target the biological substrates of the stress response are largely lacking. We propose that the clinical advancement of stress response-based therapeutics for psychiatric disorders may be hindered by ‘hidden variables’ in stress research, including considerations of behavioral study design (stressors and outcome measures), individual variability, sex differences, and the interaction of the body's stress hormone system with endogenous circadian and ultradian rhythms. We highlight key issues and suggest ways forward in stress neurobiology research that may improve the ability to assess stress mechanisms and translate preclinical findings.
Original language | English (US) |
---|---|
Pages (from-to) | 9-17 |
Number of pages | 9 |
Journal | Trends in Neurosciences |
Volume | 47 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2024 |
Keywords
- behavior
- circadian rhythm
- hypothalamic–pituitary–adrenal (HPA) axis
- individual differences
- psychiatric disorders
- sex differences
ASJC Scopus subject areas
- General Neuroscience